1.
Bioorg Med Chem Lett
; 22(2): 1247-50, 2012 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22172702
RESUMO
A series of pyrimidodiazepines was identified as potent Polo-like kinase 1 (PLK1) inhibitors. The synthesis and SAR are discussed. The lead compound 7 (RO3280) has potent inhibitory activity against PLK1, good selectivity against other kinases, and excellent in vitro cellular potency. It showed strong antitumor activity in xenograft mouse models.